Holley is a Director within CCO’s Life Sciences practice working with private capital (VC, PE, Family offices) backed biotech’s through to mid-cap commercial organisations.
Operating at the intersection of molecule and mindset, Holley has a significant track record in helping client partners build high-performing leadership teams that are needed to advance life-saving therapies and improve patient outcomes.
With a background in Biochemistry and direct career experience spanning both pharmaceutical and biotech environments, Holley is known for connecting transformational science with transformational leadership with deep networks throughout the US and Europe.